Nivolumab,Ipilimumab
BMS
['nivolumab', ' ipi ', 'melanoma', 'nivo']
#melanomaorals #asco23 2 doses of neoadjuvant nivolumab w/wo 1 dose of ipi seem to provide excellent clinical responses for advanced but resectable cssc, with the potential for organ preservation from extensive surgery 
Medical Oncology fellow at Duke University, Lebanese, husband to the best anesthesiologist, father, IO fan, trialist and skin cancer specialist to be!